Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
184.8 DKK | 0.00% | +2.65% | +3.69% |
31/05 | Bavarian Nordic Files for Supplemental US License for Smallpox-Monkeypox Vaccine | MT |
30/05 | Bavarian Nordic Gets $6.5 Million Funding for Development of Mpox Vaccine in Children | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.69% | 209.19Cr | |
+40.73% | 74TCr | |
+31.11% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+14.83% | 24TCr | |
+9.51% | 21TCr | |
-5.15% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Bavarian Nordic’s Medical Chief to Step Down by May-end